TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Alligator Bioscience AB
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
5,237
|
3,208
|
1,266 |
| Financial expenses |
134
|
58
|
23 |
| Earnings before taxes |
-22,403
|
-17,379
|
-13,859 |
| EBITDA |
-21,494
|
-16,267
|
-12,753 |
| Total assets |
10,675
|
15,239
|
32,581 |
| Current assets |
7,047
|
11,036
|
29,297 |
| Current liabilities |
8,929
|
5,799
|
4,636 |
| Equity capital |
1,068
|
8,002
|
27,601 |
| - share capital |
3,800
|
7,963
|
8,628 |
| Employees (average) |
56
|
50
|
45 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
10.0%
|
52.5%
|
84.7% |
| Turnover per employee |
94
|
64
|
28 |
| Profit as a percentage of turnover |
-427.8%
|
-541.7%
|
-1094.7% |
| Return on assets (ROA) |
-208.6%
|
-113.7%
|
-42.5% |
| Current ratio |
78.9%
|
190.3%
|
631.9% |
| Return on equity (ROE) |
-2097.7%
|
-217.2%
|
-50.2% |
| Change turnover |
2,020
|
2,045
|
840 |
| Change turnover % |
63%
|
176%
|
197% |
| Chg. No. of employees |
6
|
5
|
-5 |
| Chg. No. of employees % |
12%
|
11%
|
-10% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.